EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial

Majid Ramezani, Mahnaz Reisian, Zohreh Sajadi Hezaveh iD

PLOS ONE · 06.02.2023 · 18 (2) · e0277213

DOI: 10.1371/journal.pone.0277213 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, online erschienen am 06.02.2023. Verfasst von Majid Ramezani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Synbiotics, Hypothyroidism. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baqiyatallah University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We hypothesize that synbiotic supplementation could modulate the intestinal microbiota and subsequently, improve the condition of hypothyroid patients.

Methods

Fifty-six adult hypothyroid patients were recruited to this double-blind, placebo-controlled, randomized clinical trial. The intervention was 10 weeks of synbiotic (500 mg of 10 9 CFU/g probiotics plus fructo-oligosaccharide, n = 28) compared to placebo (lactose, magnesium stearate, talc, and silicon dioxide, n = 28). Randomization and allocation to trial groups were carried out using random number sequences drawn from https://sealedenvelope.com/ . Primary outcomes were serum thyroid stimulating hormone (TSH) and free thyroxine (FT4), and secondary outcomes were depression, quality of life, and blood pressure (BP). P -values< 0.05 were considered statistically significant.

Results

Analysis on 51 patients who completed the trial showed that TSH and depression ( p > 0.05) did not change significantly, while serum FT4 significantly increased in both groups ( p = 0.03 and p = 0.02 in symbiotic and placebo respectively). A significant decrease in systolic BP occurred only in the synbiotic group ( p = 0.05). Significant improvements occurred regarding different domains and areas of quality of life in the crude and adjusted analysis, including perceived mental health ( p = 0.02), bodily pain ( p = 0.02), general health perception ( p = 0.002), and wellbeing (p = 0.002), which were significantly higher in the synbiotic group.

Conclusions

Ten-week supplementation with synbiotic had no favorable effect on depression and TSH, but it improved blood pressure and quality of life in patients with hypothyroidism. More trials are needed to support or reject these findings.

Trial registration

IRCT20210926052583N1 , Iranian Registry of Clinical Trials (IRCT), registered October 1 st , 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynbioticsHypothyroidismAdultHumansIranQuality of LifeThyrotropinDouble-Blind Method

Substanzen

Thyrotropin

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Zohreh Sajadi Hezaveh

Förderung

  • Baqiyatallah University of Medical Sciences

Zitieren

APA

Ramezani, M., Reisian, M., & Sajadi Hezaveh, Z. (2023). The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial. PLOS ONE, 18(2), e0277213. https://doi.org/10.1371/journal.pone.0277213

Vancouver

Ramezani M, Reisian M, Sajadi Hezaveh Z. The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial. PLOS ONE. 2023;18(2):e0277213. doi:10.1371/journal.pone.0277213

BibTeX
@article{Ramezani2023,
  author = {Ramezani, Majid and Reisian, Mahnaz and Sajadi Hezaveh, Zohreh},
  title = {The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {2},
  pages = {e0277213},
  doi = {10.1371/journal.pone.0277213}
}
Kostenlos starten →